Keywords: Bristol-Myers Squibb, Collaborations with academia, Immune-oncology, II-ON

Bristol-Myers sets up global accord with academia for immune-oncology

Article | 29 May 2012

US drug major Bristol-Myers Squibb (NYSE: BMY) yesterday announced the formation of the International Immuno-Oncology Network (II-ON), a global collaboration ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Bristol-Myers Squibb

Go to company listing